Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006.
作者信息
Boudal Patrick, Sommet Agnès, Bagheri Haleh, Pathak Atul, Montastruc Jean-Louis
出版信息
Therapie. 2010 Nov-Dec;65(6):567-9. doi: 10.2515/therapie/2010065. Epub 2010 Dec 23.
PMID:21176763
Abstract
摘要
相似文献
1
Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006.口服抗凝剂引起的出血：一项关于2003年至2006年向中比利牛斯药物警戒中心报告的药物不良反应的研究。
Therapie. 2010 Nov-Dec;65(6):567-9. doi: 10.2515/therapie/2010065. Epub 2010 Dec 23.
2
Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).口服维生素K拮抗剂与姜黄（Curcuma longa）之间可能存在相互作用。
Therapie. 2014 Nov-Dec;69(6):519-20. doi: 10.2515/therapie/2014062. Epub 2014 Sep 18.
3
Neurological and digestive bleeding with Direct Oral Anticoagulants versus Vitamin K Antagonists: The differences do not stop there! A pharmacovigilance study.直接口服抗凝剂与维生素K拮抗剂所致神经和消化道出血：差异不止于此！一项药物警戒研究。
Pharmacol Res. 2017 Apr;118:119-120. doi: 10.1016/j.phrs.2016.05.024. Epub 2016 Jun 2.
4
Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.接受维生素K拮抗剂治疗的患者发生血栓形成或出血事件的相关危险因素。
J Mal Vasc. 2014 Jul;39(4):248-55. doi: 10.1016/j.jmv.2014.04.002. Epub 2014 Jun 2.
5
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?氟尿嘧啶和伴有嗜酸性粒细胞增多和全身症状的药物反应：一种未被识别的不良反应？
Eur J Clin Pharmacol. 2012 Jan;68(1):101-5. doi: 10.1007/s00228-011-1101-9. Epub 2011 Jul 27.
6
[Bleedings during vitamin K antagonist therapy associated with ciclosporin and rifampicin].[维生素K拮抗剂治疗期间与环孢素和利福平相关的出血情况]
Presse Med. 2013 May;42(5):908-11. doi: 10.1016/j.lpm.2012.07.026. Epub 2012 Oct 12.
7
Interaction between paracetamol and oral anticoagulants.对乙酰氨基酚与口服抗凝剂之间的相互作用。
Rheumatology (Oxford). 2005 Dec;44(12):1584-5. doi: 10.1093/rheumatology/kei102. Epub 2005 Oct 4.
8
Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.非常老年住院患者 INR 超过 5.0 时的过度抗凝逆转：维生素 K 给药后 24 小时 INR 反应。
Am J Med. 2011 Jun;124(6):527-33. doi: 10.1016/j.amjmed.2011.01.016.
9
Coxibs + oral anticoagulants: risk of interaction.昔布类药物与口服抗凝剂：相互作用风险
Prescrire Int. 2002 Jun;11(59):85-6.
10
[Which factors are associated to hemorrhagic adverse drug events related to antivitamin K?].
Ann Pharm Fr. 2010 Jan;68(1):36-43. doi: 10.1016/j.pharma.2009.11.003. Epub 2010 Jan 13.
引用本文的文献
1
Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR.抗血小板药物加 5-羟色胺再摄取抑制剂药物暴露患者的出血不良反应（ADR）：对法国自发报告数据库中一个有争议的 ADR 的分析。
Eur J Clin Pharmacol. 2012 Nov;68(11):1557-60. doi: 10.1007/s00228-012-1268-8. Epub 2012 Apr 15.
Zotero 插件